China’s goal is to inoculate about 70% of its population. That’s nearly a billion people. And it’s got a big challenge. It hasn’t been able to test its two vaccines in its own country. That’s because the infection rates are so low in China, they can’t perform proper clinical trials there. As The World’s Rebecca Kanthor reports, China’s success in controlling the virus is now making the vaccination process considerably more complicated.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?